Global Drug-Eluting Coating Sales Market Report 2016

COVID-19
Get in-depth analysis of the COVID-19 impact on this
Market/Industry



Notes: Sales, means the sales volume of Drug-Eluting Coating Revenue, means the sales value of Drug-Eluting Coating This report studies sales (consumption) of Drug-Eluting Coating in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Armoloy of Connecticut, Inc. (US) AST Products, Inc. (US) Biocoat, Inc. (US) Biophan Technologies, Inc. (US) Carmeda AB (Sweden) Covalon Technologies Ltd. (Canada) Hemoteq AG (Germany) Hydromer, Inc. (US) N2 Biomedical (US) Nanocopoeia, Inc. (US) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drug-Eluting Coating in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Drug-Eluting Coating in each application, can be divided into Application 1 Application 2 Application 3


Table of Contents

Global Drug-Eluting Coating Sales Market Report 2016
1 Drug-Eluting Coating Overview
    1.1 Product Overview and Scope of Drug-Eluting Coating
    1.2 Classification of Drug-Eluting Coating
        1.2.1 Type I
        1.2.2 Type II
        1.2.3 Type III
    1.3 Application of Drug-Eluting Coating
        1.3.1 Application 1
        1.3.2 Application 2
        1.3.3 Application 3
    1.4 Drug-Eluting Coating Market by Regions
        1.4.1 United States Status and Prospect (2011-2021)
        1.4.2 China Status and Prospect (2011-2021)
        1.4.3 Europe Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
    1.5 Global Market Size (Value and Volume) of Drug-Eluting Coating (2011-2021)
        1.5.1 Global Drug-Eluting Coating Sales and Growth Rate (2011-2021)
        1.5.2 Global Drug-Eluting Coating Revenue and Growth Rate (2011-2021)

2 Global Drug-Eluting Coating Competition by Manufacturers, Type and Application
     2.1 Global Drug-Eluting Coating Market Competition by Manufacturers
        2.1.1 Global Drug-Eluting Coating Sales and Market Share of Key Manufacturers (2011-2016)
        2.1.2 Global Drug-Eluting Coating Revenue and Share by Manufacturers (2011-2016)
    2.2 Global Drug-Eluting Coating (Volume and Value) by Type
        2.2.1 Global Drug-Eluting Coating Sales and Market Share by Type (2011-2016)
        2.2.2 Global Drug-Eluting Coating Revenue and Market Share by Type (2011-2016)
    2.3 Global Drug-Eluting Coating (Volume and Value) by Regions
        2.3.1 Global Drug-Eluting Coating Sales and Market Share by Regions (2011-2016)
        2.3.2 Global Drug-Eluting Coating Revenue and Market Share by Regions (2011-2016)
    2.4 Global Drug-Eluting Coating (Volume) by Application

3 United States Drug-Eluting Coating (Volume, Value and Sales Price)
    3.1 United States Drug-Eluting Coating Sales and Value (2011-2016)
        3.1.1 United States Drug-Eluting Coating Sales and Growth Rate (2011-2016)
        3.1.2 United States Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
        3.1.3 United States Drug-Eluting Coating Sales Price Trend (2011-2016)
    3.2 United States Drug-Eluting Coating Sales and Market Share by Manufacturers
    3.3 United States Drug-Eluting Coating Sales and Market Share by Type
    3.4 United States Drug-Eluting Coating Sales and Market Share by Application

4 China Drug-Eluting Coating (Volume, Value and Sales Price)
    4.1 China Drug-Eluting Coating Sales and Value (2011-2016)
        4.1.1 China Drug-Eluting Coating Sales and Growth Rate (2011-2016)
        4.1.2 China Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
        4.1.3 China Drug-Eluting Coating Sales Price Trend (2011-2016)
    4.2 China Drug-Eluting Coating Sales and Market Share by Manufacturers
    4.3 China Drug-Eluting Coating Sales and Market Share by Type
    4.4 China Drug-Eluting Coating Sales and Market Share by Application

5 Europe Drug-Eluting Coating (Volume, Value and Sales Price)
    5.1 Europe Drug-Eluting Coating Sales and Value (2011-2016)
        5.1.1 Europe Drug-Eluting Coating Sales and Growth Rate (2011-2016)
        5.1.2 Europe Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
        5.1.3 Europe Drug-Eluting Coating Sales Price Trend (2011-2016)
    5.2 Europe Drug-Eluting Coating Sales and Market Share by Manufacturers
    5.3 Europe Drug-Eluting Coating Sales and Market Share by Type
    5.4 Europe Drug-Eluting Coating Sales and Market Share by Application

6 Japan Drug-Eluting Coating (Volume, Value and Sales Price)
    6.1 Japan Drug-Eluting Coating Sales and Value (2011-2016)
        6.1.1 Japan Drug-Eluting Coating Sales and Growth Rate (2011-2016)
        6.1.2 Japan Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
        6.1.3 Japan Drug-Eluting Coating Sales Price Trend (2011-2016)
    6.2 Japan Drug-Eluting Coating Sales and Market Share by Manufacturers
    6.3 Japan Drug-Eluting Coating Sales and Market Share by Type
    6.4 Japan Drug-Eluting Coating Sales and Market Share by Application

7 Global Drug-Eluting Coating Manufacturers Analysis
    7.1 Armoloy of Connecticut, Inc. (US)
        7.1.1 Company Basic Information, Manufacturing Base and Competitors
        7.1.2 Drug-Eluting Coating Product Type, Application and Specification
            7.1.2.1 Type I
            7.1.2.2 Type II
        7.1.3 Armoloy of Connecticut, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.1.4 Main Business/Business Overview
    7.2 AST Products, Inc. (US)
        7.2.1 Company Basic Information, Manufacturing Base and Competitors
        7.2.2 103 Product Type, Application and Specification
            7.2.2.1 Type I
            7.2.2.2 Type II
        7.2.3 AST Products, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.2.4 Main Business/Business Overview
    7.3 Biocoat, Inc. (US)
        7.3.1 Company Basic Information, Manufacturing Base and Competitors
        7.3.2 127 Product Type, Application and Specification
            7.3.2.1 Type I
            7.3.2.2 Type II
        7.3.3 Biocoat, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.3.4 Main Business/Business Overview
    7.4 Biophan Technologies, Inc. (US)
        7.4.1 Company Basic Information, Manufacturing Base and Competitors
        7.4.2 Dec Product Type, Application and Specification
            7.4.2.1 Type I
            7.4.2.2 Type II
        7.4.3 Biophan Technologies, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.4.4 Main Business/Business Overview
    7.5 Carmeda AB (Sweden)
        7.5.1 Company Basic Information, Manufacturing Base and Competitors
        7.5.2  Product Type, Application and Specification
            7.5.2.1 Type I
            7.5.2.2 Type II
        7.5.3 Carmeda AB (Sweden) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.5.4 Main Business/Business Overview
    7.6 Covalon Technologies Ltd. (Canada)
        7.6.1 Company Basic Information, Manufacturing Base and Competitors
        7.6.2 Million USD Product Type, Application and Specification
            7.6.2.1 Type I
            7.6.2.2 Type II
        7.6.3 Covalon Technologies Ltd. (Canada) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.6.4 Main Business/Business Overview
    7.7 Hemoteq AG (Germany)
        7.7.1 Company Basic Information, Manufacturing Base and Competitors
        7.7.2 Chemical & Material Product Type, Application and Specification
            7.7.2.1 Type I
            7.7.2.2 Type II
        7.7.3 Hemoteq AG (Germany) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.7.4 Main Business/Business Overview
    7.8 Hydromer, Inc. (US)
        7.8.1 Company Basic Information, Manufacturing Base and Competitors
        7.8.2  Product Type, Application and Specification
            7.8.2.1 Type I
            7.8.2.2 Type II
        7.8.3 Hydromer, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.8.4 Main Business/Business Overview
    7.9 N2 Biomedical (US)
        7.9.1 Company Basic Information, Manufacturing Base and Competitors
        7.9.2  Product Type, Application and Specification
            7.9.2.1 Type I
            7.9.2.2 Type II
        7.9.3 N2 Biomedical (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.9.4 Main Business/Business Overview
    7.10 Nanocopoeia, Inc. (US)
        7.10.1 Company Basic Information, Manufacturing Base and Competitors
        7.10.2  Product Type, Application and Specification
            7.10.2.1 Type I
            7.10.2.2 Type II
        7.10.3 Nanocopoeia, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
        7.10.4 Main Business/Business Overview

8 Drug-Eluting Coating Maufacturing Cost Analysis
    8.1 Drug-Eluting Coating Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Process Analysis of Drug-Eluting Coating

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Drug-Eluting Coating Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Drug-Eluting Coating Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Drug-Eluting Coating Market Forecast (2016-2021)
    12.1 Global Drug-Eluting Coating Sales, Revenue Forecast (2016-2021)
    12.2 Global Drug-Eluting Coating Sales Forecast by Regions (2016-2021)
    12.3 Global Drug-Eluting Coating Sales Forecast by Type (2016-2021)
    12.4 Global Drug-Eluting Coating Sales Forecast by Application (2016-2021)

13 Appendix
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer




List of Tables and Figures

Figure Picture of Drug-Eluting Coating
Table Classification of Drug-Eluting Coating
Figure Global Sales Market Share of Drug-Eluting Coating by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Drug-Eluting Coating
Figure Global Sales Market Share of Drug-Eluting Coating by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Drug-Eluting Coating Revenue and Growth Rate (2011-2021)
Figure China Drug-Eluting Coating Revenue and Growth Rate (2011-2021)
Figure Europe Drug-Eluting Coating Revenue and Growth Rate (2011-2021)
Figure Japan Drug-Eluting Coating Revenue and Growth Rate (2011-2021)
Figure Global Drug-Eluting Coating Sales and Growth Rate (2011-2021)
Figure Global Drug-Eluting Coating Revenue and Growth Rate (2011-2021)
Table Global Drug-Eluting Coating Sales of Key Manufacturers (2011-2016)
Table Global Drug-Eluting Coating Sales Share by Manufacturers (2011-2016)
Figure 2015 Drug-Eluting Coating Sales Share by Manufacturers
Figure 2016 Drug-Eluting Coating Sales Share by Manufacturers
Table Global Drug-Eluting Coating Revenue by Manufacturers (2011-2016)
Table Global Drug-Eluting Coating Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Drug-Eluting Coating Revenue Share by Manufacturers
Table 2016 Global Drug-Eluting Coating Revenue Share by Manufacturers
Table Global Drug-Eluting Coating Sales and Market Share by Type (2011-2016)
Table Global Drug-Eluting Coating Sales Share by Type (2011-2016)
Figure Sales Market Share of Drug-Eluting Coating by Type (2011-2016)
Figure Global Drug-Eluting Coating Sales Growth Rate by Type (2011-2016)
Table Global Drug-Eluting Coating Revenue and Market Share by Type (2011-2016)
Table Global Drug-Eluting Coating Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drug-Eluting Coating by Type (2011-2016)
Figure Global Drug-Eluting Coating Revenue Growth Rate by Type (2011-2016)
Table Global Drug-Eluting Coating Sales and Market Share by Regions (2011-2016)
Table Global Drug-Eluting Coating Sales Share by Regions (2011-2016)
Figure Sales Market Share of Drug-Eluting Coating by Regions (2011-2016)
Figure Global Drug-Eluting Coating Sales Growth Rate by Regions (2011-2016)
Table Global Drug-Eluting Coating Revenue and Market Share by Regions (2011-2016)
Table Global Drug-Eluting Coating Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Drug-Eluting Coating by Regions (2011-2016)
Figure Global Drug-Eluting Coating Revenue Growth Rate by Regions (2011-2016)
Table Global Drug-Eluting Coating Sales and Market Share by Application (2011-2016)
Table Global Drug-Eluting Coating Sales Share by Application (2011-2016)
Figure Sales Market Share of Drug-Eluting Coating by Application (2011-2016)
Figure Global Drug-Eluting Coating Sales Growth Rate by Application (2011-2016)
Figure United States Drug-Eluting Coating Sales and Growth Rate (2011-2016)
Figure United States Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
Figure United States Drug-Eluting Coating Sales Price Trend (2011-2016)
Table United States Drug-Eluting Coating Sales by Manufacturers (2011-2016)
Table United States Drug-Eluting Coating Market Share by Manufacturers (2011-2016)
Table United States Drug-Eluting Coating Sales by Type (2011-2016)
Table United States Drug-Eluting Coating Market Share by Type (2011-2016)
Table United States Drug-Eluting Coating Sales by Application (2011-2016)
Table United States Drug-Eluting Coating Market Share by Application (2011-2016)
Figure China Drug-Eluting Coating Sales and Growth Rate (2011-2016)
Figure China Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
Figure China Drug-Eluting Coating Sales Price Trend (2011-2016)
Table China Drug-Eluting Coating Sales by Manufacturers (2011-2016)
Table China Drug-Eluting Coating Market Share by Manufacturers (2011-2016)
Table China Drug-Eluting Coating Sales by Type (2011-2016)
Table China Drug-Eluting Coating Market Share by Type (2011-2016)
Table China Drug-Eluting Coating Sales by Application (2011-2016)
Table China Drug-Eluting Coating Market Share by Application (2011-2016)
Figure Europe Drug-Eluting Coating Sales and Growth Rate (2011-2016)
Figure Europe Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
Figure Europe Drug-Eluting Coating Sales Price Trend (2011-2016)
Table Europe Drug-Eluting Coating Sales by Manufacturers (2011-2016)
Table Europe Drug-Eluting Coating Market Share by Manufacturers (2011-2016)
Table Europe Drug-Eluting Coating Sales by Type (2011-2016)
Table Europe Drug-Eluting Coating Market Share by Type (2011-2016)
Table Europe Drug-Eluting Coating Sales by Application (2011-2016)
Table Europe Drug-Eluting Coating Market Share by Application (2011-2016)
Figure Japan Drug-Eluting Coating Sales and Growth Rate (2011-2016)
Figure Japan Drug-Eluting Coating Revenue and Growth Rate (2011-2016)
Figure Japan Drug-Eluting Coating Sales Price Trend (2011-2016)
Table Japan Drug-Eluting Coating Sales by Manufacturers (2011-2016)
Table Japan Drug-Eluting Coating Market Share by Manufacturers (2011-2016)
Table Japan Drug-Eluting Coating Sales by Type (2011-2016)
Table Japan Drug-Eluting Coating Market Share by Type (2011-2016)
Table Japan Drug-Eluting Coating Sales by Application (2011-2016)
Table Japan Drug-Eluting Coating Market Share by Application (2011-2016)
Table Armoloy of Connecticut, Inc. (US) Basic Information List
Table Armoloy of Connecticut, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Armoloy of Connecticut, Inc. (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table AST Products, Inc. (US) Basic Information List
Table AST Products, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AST Products, Inc. (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table Biocoat, Inc. (US) Basic Information List
Table Biocoat, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocoat, Inc. (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table Biophan Technologies, Inc. (US) Basic Information List
Table Biophan Technologies, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biophan Technologies, Inc. (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table Carmeda AB (Sweden) Basic Information List
Table Carmeda AB (Sweden) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Carmeda AB (Sweden) Drug-Eluting Coating Global Market Share (2011-2016)
Table Covalon Technologies Ltd. (Canada) Basic Information List
Table Covalon Technologies Ltd. (Canada) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Covalon Technologies Ltd. (Canada) Drug-Eluting Coating Global Market Share (2011-2016)
Table Hemoteq AG (Germany) Basic Information List
Table Hemoteq AG (Germany) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hemoteq AG (Germany) Drug-Eluting Coating Global Market Share (2011-2016)
Table Hydromer, Inc. (US) Basic Information List
Table Hydromer, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hydromer, Inc. (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table N2 Biomedical (US) Basic Information List
Table N2 Biomedical (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure N2 Biomedical (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table Nanocopoeia, Inc. (US) Basic Information List
Table Nanocopoeia, Inc. (US) Drug-Eluting Coating Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Nanocopoeia, Inc. (US) Drug-Eluting Coating Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Coating
Figure Manufacturing Process Analysis of Drug-Eluting Coating
Figure Drug-Eluting Coating Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Coating Major Manufacturers in 2015
Table Major Buyers of Drug-Eluting Coating
Table Distributors/Traders List
Figure Global Drug-Eluting Coating Sales and Growth Rate Forecast (2016-2021)
Figure Global Drug-Eluting Coating Revenue and Growth Rate Forecast (2016-2021)
Table Global Drug-Eluting Coating Sales Forecast by Regions (2016-2021)
Table Global Drug-Eluting Coating Sales Forecast by Type (2016-2021)
Table Global Drug-Eluting Coating Sales Forecast by Application (2016-2021)

Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Enquiry Before
   Purchase
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf